HIGHLIGHTS
- who: . and colleagues from the Amity University, India have published the paper: Intranasal delivery: An attractive route for the administration of nucleic acid based therapeutics for CNS disorders, in the Journal: (JOURNAL)
- what: The primary reason for the attention to the nasal route of delivery of nucleotide drugs is the possibility of obviating the BBB and allowing direct access to the CNS. Most of the studies are on in-vitro models and a few of them have studied the transport process in preclinical models. Despite the research focus, there are several grappling issues to be . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.